Publications by authors named "Janine M Davies"

17 Publications

  • Page 1 of 1

The Impact of Geography in Hepatocellular Carcinoma: A Retrospective Population Based Study.

Curr Oncol 2021 Jan 12;28(1):396-404. Epub 2021 Jan 12.

Department of Medical Oncology, BC Cancer Vancouver, Vancouver, BC V5Z 4E6, Canada.

View Article and Find Full Text PDF
January 2021

Efficacy and Prognostic Factors for Y-90 Radioembolization (Y-90) in Metastatic Neuroendocrine Tumors with Liver Metastases.

Can J Gastroenterol Hepatol 2020 23;2020:5104082. Epub 2020 Nov 23.

Floyd and Delores Jones Cancer Institute, Virginia Mason Cancer Institute, Seattle, WA, USA.

View Article and Find Full Text PDF
November 2020

Real-world treatment attrition rates in advanced esophagogastric cancer.

World J Gastroenterol 2020 Oct;26(39):6027-6036

Department of Medicine, BC Cancer, Vancouver V5Z 4E6, Canada.

View Article and Find Full Text PDF
October 2020

Quality of Online Information Regarding Cervical Cancer.

Cureus 2020 Aug 1;12(8):e9511. Epub 2020 Aug 1.

Radiation Oncology, British Columbia Cancer Agency, Vancouver, CAN.

View Article and Find Full Text PDF
August 2020

A phase I trial of everolimus in combination with 5-FU/LV, mFOLFOX6 and mFOLFOX6 plus panitumumab in patients with refractory solid tumors.

Cancer Chemother Pharmacol 2014 Jul 13;74(1):117-23. Epub 2014 May 13.

Department of Medicine, Division of Hematology/Oncology, School of Medicine, The University of North Carolina at Chapel Hill, Physicians Office Building, 170 Manning Drive, Campus Box #7305, Chapel Hill, NC, 27599, USA,

View Article and Find Full Text PDF
July 2014

Phospho-ERK and AKT status, but not KRAS mutation status, are associated with outcomes in rectal cancer treated with chemoradiotherapy.

Radiat Oncol 2011 Sep 12;6:114. Epub 2011 Sep 12.

Department of Medicine, Division of Hematology/Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7305, USA.

View Article and Find Full Text PDF
September 2011

Treatment of metastatic colorectal cancer.

Semin Oncol 2011 Aug;38(4):552-60

Drug Development/GI Oncology Fellow, Division of Hematology/Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

View Article and Find Full Text PDF
August 2011

Optimum chemotherapy regimens for neoadjuvant therapy of hepatic colorectal metastases.

J Surg Oncol 2010 Dec;102(8):946-54

Division of Hematology/Oncology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-7305, USA.

View Article and Find Full Text PDF
December 2010

FAP, gastric cancer, and genetic counseling featuring children and young adults: a family study and review.

Fam Cancer 2010 Dec;9(4):581-8

Department of Preventive Medicine and Public Health, Creighton University School of Medicine, 2500 California Plaza, Omaha, NE 68178, USA.

View Article and Find Full Text PDF
December 2010

A phase I evaluation of the combination of vinflunine and erlotinib in patients with refractory solid tumors.

Invest New Drugs 2011 Oct 13;29(5):978-83. Epub 2010 Apr 13.

Department of Medicine, Division of Hematology-Oncology, School of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, 3rd Floor POB, CB 7305, Chapel Hill, NC 27599-7305, USA.

View Article and Find Full Text PDF
October 2011

First-line therapeutic strategies in metastatic colorectal cancer.

Oncology (Williston Park) 2008 Nov;22(13):1470-9

Division of Hematology and Oncology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27590, USA.

View Article and Find Full Text PDF
November 2008